MT
Matthias Therapeutics, LLC
SEC filingPharmaceuticals · Basking Ridge, NJ
Amount raised$50Ksold at filing
Total offering$500K$450K still open
Investors in the raise1count reported to the SEC
FiledJun 1, 2026first sale May 14, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Matthew RedlingExecutive Officer
Executive officers, directors and promoters as listed on the Form D.